共 94 条
[31]
Rosenberg Y.J., Steinberg A.D., Santoro T.J., T cells from autoimmune IL2 defective MRL-lpr/lpr mice continue to grow in vitro and produce 1L2 constitutively, J Immunol, 133, pp. 2545-2548, (1984)
[32]
Lu C.Y., Unanue E.R., Spontaneous T cell lymphokine production and enhanced macrophage la expression and tum-oricidal activity in MRL-lpr/lpr mice, Clin Immunol Immunopathol, 25, pp. 213-222, (1982)
[33]
Manolois N., Schreiber L., Nelson M., Geczy C.L., Enhanced interferon-gamma production by lymph node cells from autoimmune (MRL/1, MRL/n) mice, Clin Exp Immunol, 76, pp. 301-306, (1989)
[34]
Leibson H.J., Gefter M., Zlotnik A., Marrack P., Kappler J.W., Role of gamma-interferon in antibody-producing responses, Nature, 309, pp. 799-802, (1984)
[35]
Sidman C.L., Marshall J.D., Shulz L.D., Gray P.W., Johnson H.M., Gamma-interferon is one of several B cell-maturing lymphokines, Nature, 309, pp. 801-803, (1984)
[36]
Santoro T.J., Benjamin W.R., Oppenheim J.J., Steinberg A.D., The cellular basis for immune interferon production in autoimmune MRL-lpr/lpr mice, J Immunol, 131, pp. 265-268, (1983)
[37]
Heremans S., Billiau A., Colombatti A., Hilgers J., De Somer P., Interferon treatment of NZB mice: accelerated progression of autoimmune disease, Infect Immunol, 21, pp. 925-930, (1978)
[38]
Adam C., Thoua Y., Ronco P., Verroust P., Tovey M., Morel-Moroger L., The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W)F1 mice, Clin Exp Immunmol, 40, pp. 373-382, (1980)
[39]
Engleman E.G., Sonnenfeld G., Dauphinee M., Greenspan J.S., Talal N., McDevitt H.O., Merigan T.C., Treatment of NZW Fl mice with mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease, Arthritis Rheum, 24, pp. 1396-1402, (1981)
[40]
Seitz M., Franke M., Kirchner H., Induction of antinuclear antibodies in patients receiving treatment with human recombinant interferon gamma, Ann Rheum Dis, 47, pp. 642-644, (1898)